Apellis Pharmaceuticals Investors

37 investors on Angel Roster list Apellis Pharmaceuticals in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series B and the largest groups are based in the United States, the United Kingdom and Canada.

Investors are matched on the company name in their portfolio, so companies that share the name Apellis Pharmaceuticals can appear together.

Investors listed
37
With verified email
46%
Most common stage
Series B
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 37 Apellis Pharmaceuticals investors

The most complete profiles first. Showing 37 of 37.

  • Albert ChaVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 81 more

    Verified email available

  • Jonathan LeffVerified

    Venture Capital, Investor · United States

    SeedSeries BHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 66 more

    Verified email available

  • Mahendra ShahVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Verified email available

  • Nathan DauVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Verified email available

  • Richard GasterVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more

    Verified email available

  • Sarah BhagatVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Alan ColowickVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Brian FriedmanVerified

    Private Equity Firm · United States

    AdvertisingHealth CareCybersecurityWomen Founded

    Portfolio: Core Security, LinkBee, Phase Change Solutions, Konarka Technologies and 8 more

    Verified email available

  • Catherine PoulinVerified

    Private Equity Firm, Investment Partner · Canada

    Health CareInvestment ManagementLife ScienceEmerging Markets

    Portfolio: HighLife, CurvaFix, Aprea, F2G and 19 more

    Verified email available

  • David CogutVerified

    Private Equity Firm · United States

    AdvertisingHealth CareCybersecurityWomen Founded

    Portfolio: Core Security, LinkBee, Phase Change Solutions, Konarka Technologies and 8 more

    Verified email available

  • David PezeshkiVerified

    Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more

    Verified email available

  • James CavanaughVerified

    Venture Capital · United States

    Health CareWearablesGeneticsE-commerce

    Portfolio: Apofore, Catalyst Biosciences, Avidia, Proteostasis Therapeutics and 52 more

    Verified email available

  • Jason PittsVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Joel HaneyVerified

    Private Equity Firm · United States

    AdvertisingHealth CareCybersecurityWomen Founded

    Portfolio: Core Security, LinkBee, Phase Change Solutions, Konarka Technologies and 8 more

    Verified email available

  • Mary CanningVerified

    Venture Capital, Private Equity Firm, Micro VC · United Kingdom

    Health CareGeneticsChemicalLife Science

    Portfolio: Confluence Life Sciences, Funderbeam, Edinburgh Molecular Imaging, Topas Therapeutics and 14 more

    Verified email available

  • Mike PowellVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Qi ZhuVerified

    Venture Capital, Private Equity Firm · China

    Health CareHospitalsWomen FoundedInvestment Management

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Verified email available

  • Aaron Royston, M.D.

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, HistoWiz and 35 more

    Contact details available

  • Frank Kung

    Venture Capital, Founder, Private Equity Firm · United States

    Series BHealth CareHospitalsWomen FoundedInvestment Management

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 76 more

    Contact details available

  • Jaume Pons

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more

    Contact details available

  • Maha Katabi, PhD, CFA

    Hedge Fund, Venture Capital, Investor · Canada

    SeedHealth CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 64 more

    Contact details available

  • Perry Nisen

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Yvonne Yamanaka

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more

    Contact details available

  • Aksana Labokha

    Micro VC · United Kingdom

    Health CareGeneticsChemicalLife Science

    Portfolio: Confluence Life Sciences, Funderbeam, Edinburgh Molecular Imaging, Topas Therapeutics and 14 more

    Contact details available

  • Alain J. Gilbert

    Private Equity Firm, Investment Partner · France

    Health CareInvestment ManagementLife ScienceEmerging Markets

    Portfolio: HighLife, CurvaFix, Aprea, F2G and 19 more

    Contact details available

  • Alfred Yue

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Andrew Goldberg

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Contact details available

  • Anuj Kamdar

    Private Equity Firm · United States

    AdvertisingHealth CareCybersecurityWomen Founded

    Portfolio: Core Security, LinkBee, Phase Change Solutions, Konarka Technologies and 8 more

    Contact details available

  • Elizabeth Roper

    Venture Capital, Private Equity Firm, Micro VC · United Kingdom

    Health CareGeneticsChemicalLife Science

    Portfolio: Confluence Life Sciences, Funderbeam, Edinburgh Molecular Imaging, Topas Therapeutics and 14 more

    Contact details available

  • Hooman Shahlavi

    Hedge Fund, Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Marc

    Private Equity Firm, Investment Partner · Canada

    Health CareInvestment ManagementLife ScienceEmerging Markets

    Portfolio: HighLife, CurvaFix, Aprea, F2G and 19 more

    Contact details available

  • Matthew Miessau

    Venture Capital, Private Equity Firm, Micro VC · United States

    Health CareGeneticsChemicalLife Science

    Portfolio: Confluence Life Sciences, Funderbeam, Edinburgh Molecular Imaging, Topas Therapeutics and 14 more

    Contact details available

  • Nina Feng

    Venture Capital, Private Equity Firm · Taiwan

    Health CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Contact details available

  • Peter Finan

    Micro VC · United Kingdom

    Health CareGeneticsChemicalLife Science

    Portfolio: Confluence Life Sciences, Funderbeam, Edinburgh Molecular Imaging, Topas Therapeutics and 14 more

    Contact details available

  • Shan Fu

    Venture Capital, Private Equity Firm · China

    Health CareHospitalsWomen FoundedInvestment Management

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Contact details available

  • Sinclair Dunlop

    Venture Capital, Private Equity Firm, Micro VC · United Kingdom

    Health CareGeneticsChemicalLife Science

    Portfolio: Confluence Life Sciences, Funderbeam, Edinburgh Molecular Imaging, Topas Therapeutics and 14 more

    Contact details available

  • Ulrike Schambeck

    Private Equity Firm · United States

    AdvertisingHealth CareCybersecurityWomen Founded

    Portfolio: Core Security, LinkBee, Phase Change Solutions, Konarka Technologies and 8 more

    Contact details available

Frequently asked questions

How many Apellis Pharmaceuticals investors are on Angel Roster?

Angel Roster lists 37 Apellis Pharmaceuticals investors. 17 of them (46%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (26), Private Equity Firms (25) and Micro VC Firms (6). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Apellis Pharmaceuticals investors invest in?

Among those that list a stage, the most common are Series B (8) and Seed (5).

Where are Apellis Pharmaceuticals investors based?

Most are based in the United States (25), the United Kingdom (5) and Canada (3).

Which companies have Apellis Pharmaceuticals investors backed?

The most-backed portfolio companies among them are Medeor Therapeutics (17), Bolt Biotherapeutics (17), Visen Pharmaceuticals (17), Aclaris Therapeutics (17) and Checkmate Pharmaceuticals (17).

How do I contact Apellis Pharmaceuticals investors?

Create a free Angel Roster account to search and filter all 37, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.